Faced with staffing shortages, administrative strain and geographic barriers, rural hospitals are increasingly adopting AI to expand care access and ease pressure on front-line teams. Rather than ...

This story was originally published by Chalkbeat Indiana. Indiana lawmakers have advanced a bill that could lead to more high school students taking the Classic Learning Test instead of the SAT or ACT ...

Forbes contributors publish independent expert analyses and insights. Chelsea writes about marketing, freelance life, and entrepreneurship. LinkedIn is one of the most-cited sources by AI chatbots. A ...

I don’t want to admit it, but I did spend a lot of money online this holiday shopping season. And unsurprisingly, some of those purchases didn’t meet my expectations. A photobook I bought was damaged ...

The Selfix case has a 1.6-inch screen on the back and a microSD card slot to expand your phone’s storage. The Selfix case has a 1.6-inch screen on the back and a microSD card slot to expand your ...

Learning how to use toner pads the right way can be a game changer for your skin care routine: They’re convenient, effective, and genuinely satisfying to swipe over your skin. But before you go nuts ...

Scientists are testing a novel way to measure cosmic expansion using time delays in gravitationally lensed quasars. Their results match “local” measurements but clash with early-universe estimates, ...

The move comes as the Supreme Court also appears poised to put antitrust enforcement by the Federal Trade Commission under his control. By Charlie Savage Reporting from Washington By thrusting himself ...

AUSTIN, Texas — Nine new businesses have been granted conditional cannabis dispensary licenses as Texas expands its Compassionate Use Program for medical marijuana. The new companies include Central ...

Google Cloud is locking in a multi-year partnership with AI coding startup Replit Google is betting on Replit as a breakout platform in the fast-growing vibe-coding phenomenon Replit will expand use ...

AbbVie is seeking European approval of expanded use of its migraine drug atogepant in adults following strong results from a phase three study. The North Chicago drugmaker is presenting results of ...